Literature DB >> 21769119

Targeted therapies: Go on, leave me BRCA-less!

M Teresa Villanueva.   

Abstract

Entities:  

Year:  2011        PMID： 21769119     DOI： 10.1038/nrclinonc.2011.108

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.

Authors:  Neil Johnson; Yu-Chen Li; Zandra E Walton; Katherine A Cheng; Danan Li; Scott J Rodig; Lisa A Moreau; Christine Unitt; Roderick T Bronson; Huw D Thomas; David R Newell; Alan D D'Andrea; Nicola J Curtin; Kwok-Kin Wong; Geoffrey I Shapiro
Journal:  Nat Med       Date:  2011-06-26       Impact factor: 53.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.